FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sagent Pharmaceuticals methylPREDNISolone Sodium Succinate for Recall

methylPREDNISolone Sodium Succinate for Injection, USP, 1 gram* per vial, Single-Dose V…

Sagent Pharmaceuticals Inc · Schaumburg, IL

Risk level
Class II
Reported by FDA
Mar 21, 2018
Recall ID
D-0588-2018
Check your lot numberHow we source this data

Summary

Sagent Pharmaceuticals recalled methylPREDNISolone Sodium Succinate for starting Mar 5, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0588-2018 on Mar 21, 2018. Reason: Failed Impurities/Degradation Specifications: High out of specification results for an impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: High out of specification results for an impurity.

Product description

methylPREDNISolone Sodium Succinate for Injection, USP, 1 gram* per vial, Single-Dose Vial, Rx only, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-810-30.

Lot numbers, UPCs & expiration codes

Lot #: AJP701, AJP702, Exp. Dec-2018; AJP601, Exp. Jul-2018; AJP703, Exp. Aug-2019

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0588-2018
Classification
Class II
Status
Terminated
Recall initiated
Mar 5, 2018
FDA report date
Mar 21, 2018
Quantity
48,964 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sagent Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0588-2018, exactly as published.

Show all FDA fields
City
Schaumburg
State
IL
Status
Terminated
Country
United States
Event ID
79419
Address
1901 N Roselle Rd Ste 700
Code information
Lot #: AJP701, AJP702, Exp. Dec-2018; AJP601, Exp. Jul-2018; AJP703, Exp. Aug-2019
Postal code
60195-3194
Report date
Mar 21, 2018
Product type
Drugs
Recall number
D-0588-2018
Classification
Class II
Recalling firm
Sagent Pharmaceuticals Inc
Product quantity
48,964 vials
Termination date
Apr 15, 2020
Reason for recall
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
methylPREDNISolone Sodium Succinate for Injection, USP, 1 gram* per vial, Single-Dose Vial, Rx only, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-810-30.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Mar 5, 2018
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 12, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0588-2018, published Mar 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls